Gyre Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-55.0M | $-55.0M | — | $3.6M |
| FY2021 | $-83.8M | $-84.6M | $839.0K | $3.4M |
| FY2022 | $10.7M | $5.7M | $5.0M | $13.4M |
| FY2023 | $25.9M | $17.4M | $8.5M | $7.3M |
| FY2024 | $-3.6M | $-6.0M | $2.3M | $831.0K |